Compounded Hormones vs FDA-Approved: The Real Differences Explained

Few topics in menopause care generate as much heated debate as compounded hormones versus FDA-approved products. On one side, you'll hear that compounding is unregulated, inconsistent, and potentially dangerous. On the other, you'll hear that compounded hormones are more "natural," more personalized, and superior to the one-size-fits-all products from pharmaceutical companies.

The truth, as it usually does, lives somewhere in the middle. Both options have legitimate places in menopause care, both have limitations, and the right choice depends on your specific situation. Here's an honest, evidence-based look at the real differences.

Let's define our terms

FDA-approved hormones

These are hormone products that have gone through the FDA's approval process, which requires clinical trials demonstrating safety and efficacy, standardized manufacturing processes, consistent dosing from batch to batch, and ongoing quality monitoring by the FDA. Examples include:

• Estradiol patches — Vivelle-Dot, Climara, Dotti, and generics
• Estradiol gel — EstroGel, Divigel
• Oral estradiol — Estrace and generics
• Micronized progesterone — Prometrium and generics
• Combination products — Bijuva (estradiol + progesterone in one capsule), CombiPatch
• Vaginal estrogen — Estrace cream, Vagifem/Yuvafem tablets, Estring ring, Imvexxy

It's worth noting that many FDA-approved hormone products are bioidentical — meaning they're molecularly identical to the hormones your body produces. Estradiol is estradiol whether it comes from a pharmaceutical manufacturer or a compounding pharmacy. The term "bioidentical" doesn't mean "compounded," despite how it's sometimes marketed.

Compounded hormones

Compounded hormones are custom-prepared by compounding pharmacies according to a prescription from your healthcare provider. Compounding pharmacies can create formulations in doses, combinations, and delivery methods that aren't available in FDA-approved products.

Compounding pharmacies are regulated, but differently from pharmaceutical manufacturers. They're overseen by state boards of pharmacy and, if they ship across state lines, by the FDA under Section 503B of the Federal Food, Drug, and Cosmetic Act. However, they don't go through the same clinical trial process as FDA-approved products.

Common compounded hormone formulations include:

• Topical creams containing estradiol, estriol, testosterone, progesterone, or combinations
• Bi-Est — a combination of estradiol and estriol (typically 80/20 or 50/50 ratio)
• Tri-Est — a combination of estradiol, estriol, and estrone
• DHEA — dehydroepiandrosterone, a precursor hormone
• Testosterone creams — in doses appropriate for women
• Subcutaneous pellets — small hormone pellets implanted under the skin
• Troches and sublingual tablets — dissolved under the tongue

The honest case for FDA-approved products

FDA-approved hormones have several genuine advantages that are worth understanding:

Clinical trial data

This is the big one. FDA-approved products have been studied in clinical trials — sometimes involving thousands of women — that provide data on safety, efficacy, and side effects. When your provider prescribes Vivelle-Dot or Prometrium, they can reference decades of research on those specific products.

The WHI study, for all its flaws, used specific FDA-approved products (Premarin and Prempro). The 20+ years of follow-up data we have on HRT safety is based primarily on FDA-approved formulations. When The Menopause Society or the Endocrine Society makes recommendations about HRT, they're largely based on studies using FDA-approved products.

Dosing consistency

FDA-approved products must meet strict standards for consistency. Every patch of Vivelle-Dot 0.05mg delivers the same amount of estradiol. Every capsule of Prometrium 100mg contains the same amount of micronized progesterone. This consistency is guaranteed by manufacturing standards and FDA oversight.

This matters because hormone dosing is precise work. Small differences in the amount of estrogen or progesterone you receive can affect both efficacy and side effects.

Insurance coverage

FDA-approved hormones are generally covered by insurance, and many are available as affordable generics. Generic estradiol patches can cost as little as $15-30/month with insurance. Compounded formulations are typically not covered by insurance and can cost significantly more — often $50-200+/month depending on the formulation.

Quality oversight

Pharmaceutical manufacturers are subject to extensive FDA inspections, Good Manufacturing Practice (GMP) requirements, and recall procedures. While no system is perfect, the oversight infrastructure is robust and well-established.

The honest case for compounded hormones

Compounding also has legitimate advantages in specific situations:

Testosterone for women

This is arguably the strongest case for compounding. There is currently no FDA-approved testosterone product for women in the United States. Male testosterone products exist (AndroGel, Testim, etc.), but the doses are far too high for female use. Women who need testosterone therapy — and many do, especially after oophorectomy or for persistent low libido, fatigue, or brain fog — currently have two options: carefully dose a male product (using a fraction of the amount) or get a compounded formulation in an appropriate female dose.

Most menopause specialists who prescribe testosterone for women use compounded products because they can specify the exact concentration needed. This is a clear gap in the FDA-approved product market, and compounding fills it.

Dose customization

FDA-approved products come in fixed doses. If you need a dose that falls between available options — say, 0.03mg of estradiol when the available patches come in 0.025mg and 0.05mg — compounding can provide exactly that. For women who are sensitive to small dose changes, this precision can be valuable.

Allergen and filler avoidance

Some women are sensitive to ingredients in FDA-approved products — the adhesive in patches, the peanut oil in Prometrium capsules, dyes, or other inactive ingredients. Compounding pharmacies can create formulations without specific allergens or irritants.

This is a real consideration for women with allergies or sensitivities, not a marketing gimmick. If you break out in a rash from every patch you try, or if you have a peanut allergy and can't take Prometrium, compounding offers a practical solution.

Combination convenience

Compounding pharmacies can combine multiple hormones into a single preparation — estrogen, progesterone, and testosterone in one cream, for example. For women taking multiple hormones, this can simplify their routine significantly.

Delivery method options

Compounding pharmacies can create formulations in delivery methods not available in FDA-approved products — sublingual troches, specific cream bases optimized for absorption, vaginal preparations with custom concentrations, and pellets for subcutaneous insertion.

The concerns about compounding — addressed honestly

Dosing variability

This is the most commonly cited concern, and it has some basis. A 2001 FDA analysis and subsequent studies have found variability in the potency of some compounded hormone products — meaning the actual amount of hormone in a preparation didn't always match what was on the label.

However, this concern applies primarily to lower-quality compounding pharmacies. High-quality compounding pharmacies — particularly those accredited by the Pharmacy Compounding Accreditation Board (PCAB) or that follow USP <795> and <797> standards — maintain rigorous quality controls. Not all compounding pharmacies are equal, and choosing a reputable one matters enormously.

Lack of clinical trial data

Compounded formulations haven't been through the clinical trial process, which means we don't have the same depth of safety and efficacy data that we have for FDA-approved products. This is a legitimate limitation.

That said, the active ingredients in most compounded formulations are the same bioidentical hormones studied in clinical trials — estradiol, progesterone, testosterone. The molecular structures are identical. What's different is the specific formulation, vehicle, and dose combination. The argument that compounded bioidentical estradiol is fundamentally different from FDA-approved bioidentical estradiol doesn't hold up chemically.

Estriol: the controversial ingredient

Many compounded formulations include estriol — a weaker form of estrogen that's naturally produced in significant quantities during pregnancy. Estriol is widely used in Europe (where it's available in FDA-equivalent-approved products) but is not approved by the FDA in the U.S.

Proponents argue that estriol is gentler and safer than estradiol. Critics note that clinical evidence for estriol's efficacy in menopause symptom relief is limited compared to estradiol, and that its inclusion in Bi-Est and Tri-Est formulations complicates dosing because the total estrogenic effect is harder to predict.

The honest answer: estriol appears to be safe based on available evidence, but we have significantly more data on estradiol. If your provider recommends a formulation containing estriol, ask them to explain their specific reasoning for your situation.

Saliva testing and "hormone balancing"

Some compounding-oriented practices rely heavily on saliva hormone testing to guide dosing, and market their approach as "hormone balancing." Major medical organizations — including The Menopause Society, the Endocrine Society, and ACOG — have cautioned against routine saliva testing for hormone levels, noting that it's less reliable than serum (blood) testing and that hormone levels fluctuate throughout the day, making single measurements of limited value.

This doesn't invalidate all compounded hormone use. But if a practice is heavily centered on saliva testing and promises to achieve perfect "hormone balance" based on those results, approach with healthy skepticism. The best menopause specialists treat symptoms, not lab numbers.

When FDA-approved makes more sense

• You're starting HRT for the first time and want to begin with the most well-studied option
• Cost and insurance coverage are important factors
• You don't need testosterone (the main gap in the FDA-approved market)
• You want the reassurance of standardized, clinically-tested products
• A standard dose works well for you
• You don't have allergies or sensitivities to available products

When compounding makes more sense

• You need testosterone therapy (no FDA-approved option for women)
• You're allergic or sensitive to ingredients in available FDA-approved products
• You need a dose that doesn't exist in FDA-approved formulations
• You prefer a delivery method (like pellets or troches) not available in FDA-approved forms
• You want to combine multiple hormones into a single preparation
• FDA-approved options haven't worked well for you and your provider wants to try a different approach

How to choose a reputable compounding pharmacy

If you and your provider decide that compounded hormones are the right choice for your situation, quality matters. Here's what to look for:

• PCAB accreditation — The Pharmacy Compounding Accreditation Board (a subsidiary of the Accreditation Commission for Health Care) accredits compounding pharmacies that meet rigorous quality standards. This is currently the gold standard for compounding pharmacy accreditation.
• USP compliance — The pharmacy should follow United States Pharmacopeia (USP) standards for compounding, particularly USP <795> (non-sterile compounding) and <797> (sterile compounding).
• Third-party testing — Some pharmacies voluntarily submit their products for independent potency testing. Ask if this is part of their quality assurance process.
• Transparent practices — A good compounding pharmacy will be willing to discuss their sourcing, quality controls, and testing procedures. If they're evasive about these questions, look elsewhere.
• Provider recommendation — Your prescribing provider should be able to recommend a compounding pharmacy they've worked with and trust.

The bottom line

The compounded vs. FDA-approved debate is often presented as a binary choice between "natural and personalized" versus "regulated and safe." In reality, both can be high-quality and both can be suboptimal, depending on the specific products, the pharmacy or manufacturer, and how they're prescribed.

For most women starting HRT, FDA-approved products are a reasonable first choice — they're well-studied, consistent, covered by insurance, and effective. For women who need testosterone, who can't tolerate available FDA products, or who have specific clinical needs that compounding can address, compounded hormones serve an important role.

The most important factor isn't where your hormones come from — it's whether they're prescribed by a knowledgeable provider who understands menopause medicine, who's chosen your formulation and dose based on your individual needs, and who's monitoring your response over time. That's true whether your prescription goes to CVS or a compounding pharmacy.

Don't let anyone scare you away from FDA-approved products by calling them "synthetic" (most are bioidentical). And don't let anyone scare you away from compounding by calling it "unregulated" (quality compounding pharmacies are highly regulated). Ask questions, understand what you're taking and why, and work with a provider who can explain their reasoning clearly.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider about which hormone therapy approach is right for your individual situation.